background
influenza
viru
present
signific
challeng
public
health
caus
season
epidem
occasion
pandem
nanopor
metagenom
sequenc
potenti
deploy
nearpati
test
provid
rapid
diagnosi
infect
rationalis
antimicrobi
therapi
support
intervent
infect
control
studi
aim
evalu
applic
sequenc
approach
routin
laboratori
test
influenza
clinic
set
conduct
nanopor
metagenom
sequenc
respiratori
sampl
uk
hospit
influenza
season
compar
result
routin
molecular
diagnost
test
investig
drug
resist
genet
divers
nosocomi
transmiss
use
influenza
sequenc
data
result
metagenom
sequenc
sensit
specif
detect
influenza
virus
compar
diagnost
standard
cepheid
xpressbiofir
filmarray
respiratori
panel
identifi
genom
oseltamivir
resist
mutat
na
protein
potenti
associ
emerg
distinct
intrasubtyp
reassort
whole
genom
phylogeni
refut
suspicion
transmiss
cluster
infecti
diseas
ward
identifi
two
cluster
like
reflect
nosocomi
transmiss
associ
predomin
strain
circul
commun
also
detect
rang
potenti
pathogen
virus
bacteria
metagenom
conclus
nanopor
metagenom
sequenc
detect
emerg
novel
variant
drug
resist
provid
time
insight
antimicrobi
stewardship
right
reserv
reus
allow
without
permiss
vaccin
design
gener
full
genom
contribut
investig
manag
nosocomi
outbreak
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
influenza
virus
iav
envelop
virus
orthomyxovirida
famili
segment
rna
genom
iav
caus
season
epidem
occasion
pandem
present
signific
challeng
public
health
season
epidem
estim
caus
half
million
death
global
year
primarili
among
young
children
elderli
estim
suggest
futur
pandem
could
infect
world
popul
caus
million
death
within
six
month
track
character
circul
influenza
virus
human
anim
popul
critic
provid
earli
warn
emerg
novel
variant
high
virul
inform
vaccin
design
directfromsampl
metagenom
sequenc
potenti
identifi
viral
bacteri
pathogen
within
individu
clinic
sampl
genom
inform
gener
comprehens
character
pathogen
enabl
investig
epidemiolog
transmiss
oxford
nanopor
technolog
ont
third
gener
sequenc
technolog
gener
longread
data
realtim
success
appli
realtim
surveil
ebola
zika
lassa
outbreak
ont
metagenom
sequenc
potenti
deploy
nearpati
test
provid
rapid
accur
diagnosi
infect
inform
antimicrobi
therapi
support
intervent
infect
prevent
control
recent
demonstr
proofofprincipl
directfromsampl
nanopor
metagenom
sequenc
protocol
influenza
virus
sensit
specif
compar
routin
clinic
diagnost
test
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
describ
nanopor
metagenom
sequenc
directli
clinic
respiratori
sampl
uk
hospit
influenza
season
evalu
applic
approach
routin
laboratori
test
influenza
investig
optimis
still
requir
assay
deploy
clinic
practic
assess
perform
experiment
protocol
headtohead
routin
clinic
laboratori
test
use
influenza
sequenc
data
investig
drug
resist
genet
divers
nosocomi
transmiss
event
demonstr
divers
benefit
gain
metagenom
approach
diagnost
residu
materi
collect
anonymis
throat
swab
nasal
swab
nasopharyng
aspir
submit
clinic
diagnost
laboratori
oxford
univers
hospit
nh
foundat
trust
influenza
season
prior
metagenom
sequenc
sampl
test
diagnost
laboratori
base
standard
oper
protocol
use
either
xpert
xpress
flursv
assay
cepheid
sunnyval
ca
usa
detect
influenza
ab
respiratori
syncyti
viru
respiratori
panel
assay
biofir
diagnost
salt
lake
citi
ut
usa
detect
panel
viral
bacteri
respiratori
pathogen
xpert
report
quantit
diagnost
result
ct
valu
detect
pathogen
report
binari
result
pathogen
detect
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
first
laboratori
diagnosi
influenza
hospit
laboratori
season
made
octob
sampl
collect
ran
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
method
sampl
process
sequenc
independ
singl
primer
amplif
describ
nanopor
sequenc
genom
phylogenet
analys
describ
supplementari
materi
nanopor
metagenom
sequenc
sampl
process
librari
prepar
time
protocol
eight
hour
sequenc
time
hour
thu
total
turnaround
time
sampl
hour
team
three
member
prepar
sequenc
librari
sampl
within
day
complet
sequenc
run
influenzaposit
sampl
within
day
commenc
sequenc
figur
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
nanopor
sequenc
gener
mean
total
read
per
sampl
tabl
retriev
hazara
viru
read
spike
intern
control
genom
copiesml
sampl
sampl
hazara
viru
read
identifi
influenza
neg
compar
low
total
cdna
concentr
follow
amplif
therefor
repeat
sequenc
sampl
suffici
remain
materi
addit
linear
polyacrylamid
carrier
produc
hazara
viru
read
sampl
taken
togeth
therefor
retriev
hazard
intern
control
sampl
possibl
retest
carrier
xpert
xpress
influenzaposit
sampl
sensit
rang
read
figur
iav
read
present
sampl
ct
maximum
ct
valu
sampl
iav
read
strong
correl
ct
valu
iav
read
number
r
p
figur
ratio
iav
hazara
viru
read
r
p
figur
remain
influenzaposit
sampl
iav
read
gener
nanopor
sequenc
lower
viral
titr
reflect
higher
ct
valu
rang
iav
read
present
influenzaneg
sampl
specif
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
among
sampl
gener
iav
read
could
determin
ha
subtyp
sampl
design
blue
vs
red
dot
figur
could
determin
ha
subtyp
sampl
ct
maximum
ct
sampl
figur
retriev
consensu
sequenc
genom
coverag
among
subtyp
figur
genom
coverag
sampl
ct
valu
show
substanti
variat
associ
sampl
attribut
abl
measur
includ
sampl
type
percentag
human
bacteri
read
data
shown
consensu
sequenc
cover
drugresist
posit
identifi
amino
acid
mutat
protein
sequenc
known
widespread
confer
reduc
inhibit
amantadin
sequenc
sampl
carri
amino
acid
mutat
na
protein
report
confer
reduc
inhibit
oseltamivir
analys
map
data
sampl
read
carri
mutat
drug
resist
mutat
na
protein
associ
oseltamivir
resist
present
dataset
major
sequenc
cluster
within
clade
one
sequenc
clade
figur
comparison
phylogeni
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
show
ha
na
segment
individu
sampl
cluster
within
clade
except
sampl
distinct
genotyp
segment
cluster
within
clade
na
segment
within
clade
denot
subsequ
rgenotyp
suggest
intrasubtyp
reassort
figur
interestingli
mutat
occur
sampl
sampl
motiv
us
investig
preval
mutat
season
iav
use
publish
sequenc
last
two
influenza
season
dataset
sequenc
carri
mutat
ha
na
segment
clade
proport
sequenc
mutat
increas
belong
rgenotyp
result
suggest
potenti
associ
increas
preval
mutat
emerg
distinct
rgenotyp
includ
put
clinic
cluster
eight
influenzaposit
sampl
group
collect
patient
infecti
diseas
ward
day
period
aim
investig
potenti
nosocomi
transmiss
event
figur
could
determin
ha
subtyp
six
sampl
three
three
among
two
sampl
one
consensu
sequenc
full
genom
coverag
minimum
span
tree
mst
sequenc
show
sampl
differ
snp
figur
despit
collect
day
patient
ward
result
refut
suspicion
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
figur
also
demonstr
three
sequenc
ident
cluster
one
patient
infecti
diseas
ward
sampl
one
recent
infecti
diseas
ward
care
emerg
assess
unit
eau
sampl
one
eau
coupl
day
complex
medicin
unit
discharg
sampl
two
ident
sequenc
cluster
differ
cluster
snp
patient
respiratori
ward
taken
two
day
apart
one
sequenc
sampl
differ
cluster
snp
acut
admit
patient
eau
three
week
later
remain
four
sequenc
includ
sampl
refut
cluster
three
patient
elsewher
hospit
separ
cluster
cluster
snp
result
suggest
cluster
patient
infecti
diseas
ward
cluster
patient
chest
ward
like
reflect
nosocomi
transmiss
clear
link
cluster
patient
cluster
patient
acut
admit
eau
patient
sampl
one
patient
cluster
sampl
eau
patient
posit
influenza
first
day
admiss
hospit
suggest
sampl
may
associ
predomin
strain
circul
commun
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
phylogenet
analysi
segment
show
sequenc
cluster
within
clade
figur
full
genom
level
found
evid
phylogenet
cluster
iav
recov
hospit
suggest
repres
independ
introduct
rather
genom
close
relat
genom
recov
uk
season
figur
genom
close
relat
sequenc
within
snp
close
relat
sequenc
uk
among
influenzaneg
respiratori
sampl
sequenc
test
posit
anoth
viru
clinic
diagnost
laboratori
small
dataset
metagenom
sequenc
dataset
sensit
hmpv
rsv
piv
sensit
coronaviru
enteroviru
specif
high
five
virus
tabl
five
influenzaposit
sampl
iav
read
gener
sequenc
also
retriev
read
virus
includ
human
coronaviru
tabl
influenzaneg
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
tabl
organ
may
repres
agent
respiratori
infect
also
commens
colonis
flora
absenc
detail
clinic
metadata
unabl
explor
like
contribut
patholog
studi
conduct
nanopor
metagenom
sequenc
iav
directli
clinic
respiratori
sampl
uk
hospit
influenza
season
report
headtohead
comparison
routin
clinic
diagnost
test
total
turnaround
time
metagenom
sequenc
sampl
hour
process
clinic
sampl
gener
sequenc
data
clinic
sampl
day
period
turnaround
time
still
slower
laboratori
diagnost
test
approach
requir
invest
labour
sequencinganalysi
time
potenti
reduc
simplif
wet
laboratori
protocol
implement
realtim
bioinformat
analysi
read
gener
timeli
crucial
deploy
intern
vaccin
strategi
februari
determin
influenza
vaccin
use
follow
northern
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
figur
due
substanti
increas
virus
sever
region
sinc
novemb
associ
low
vaccin
effect
onemonth
delay
rais
concern
timeli
vaccin
manufactur
distribut
upcom
influenza
season
within
cohort
clade
sampl
collect
januari
conduct
rapidturnaround
sequenc
routin
assay
complet
genom
sequenc
could
avail
hour
first
strain
clade
countri
offici
report
public
health
england
march
timelin
illustr
routin
laboratori
sequenc
would
allow
earlier
genet
character
provid
translat
advantag
influenza
surveil
monitor
chang
proport
genet
divers
strain
contribut
time
insight
seanson
epidemiolog
vaccin
design
sequenc
data
show
sensit
iav
compar
exist
laboratori
diagnost
test
consist
previou
studi
smaller
dataset
optim
need
improv
sensit
protocol
clinic
sampl
lower
viral
titr
ct
valu
potenti
method
includ
deplet
host
bacteri
rna
reduc
amount
nontarget
nucleic
acid
present
enrich
target
via
probe
primer
amplif
data
show
addit
carrier
improv
detect
intern
spike
control
sampl
low
total
cdna
like
due
improv
purif
reduc
degrad
lower
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
concentr
rna
thu
intend
incorpor
approach
routin
part
protocol
futur
na
mutat
iav
associ
reduc
suscept
oseltamivir
sinc
influenza
season
among
iav
test
global
season
one
strain
south
korea
show
reduc
suscept
oseltamivir
due
mutat
analysi
demonstr
iav
carri
mutat
season
belong
distinct
genotyp
gener
intrasubtyp
reassort
clade
previou
studi
report
similar
observ
emerg
rapid
global
spread
adamantan
resist
iav
confer
mutat
protein
associ
singl
genotyp
gener
intrasubtyp
reassort
occur
almost
circul
iav
global
caus
cessat
use
adamantan
treat
influenza
genesi
preval
distribut
clinic
impact
mutat
merit
addit
studi
evalu
potenti
implic
clinic
use
oseltamivir
wide
use
firstlin
agent
treatment
indic
whole
genom
sequenc
provid
high
resolut
character
spatiotempor
spread
viral
outbreak
previou
studi
use
target
enrich
combin
next
gener
sequenc
investig
nosocomi
transmiss
influenza
studi
demonstr
applic
nanopor
metagenom
sequenc
purpos
sequenc
data
allow
us
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
refut
suspicion
singl
transmiss
cluster
infecti
diseas
ward
although
small
number
whole
genom
gener
limit
extent
could
draw
conclus
transmiss
among
specif
patient
group
furthermor
dataset
reveal
two
clinic
cluster
like
repres
nosocomi
transmiss
infecti
diseas
ward
chest
ward
show
proof
concept
nanopor
metagenom
sequenc
identifi
nosocomi
transmiss
potenti
inform
infect
prevent
control
practic
base
small
exploratori
dataset
protocol
show
sensit
detect
human
metapneumoviru
parainfluenza
respiratori
syncyti
viru
compar
routin
clinic
diagnost
test
lower
sensit
enteroviru
coronaviru
could
due
low
viral
titr
sampl
although
abl
confirm
assay
nonquantit
test
anoth
possibl
sispa
method
less
sensit
certain
virus
moreov
influenza
b
viru
read
present
influenzaposit
sampl
congruent
global
low
level
influenza
b
viru
season
work
need
determin
limit
detect
optim
laboratori
bioinformat
protocol
improv
sensit
wider
rang
potenti
pathogen
organ
studi
includ
limit
cohort
sampl
stratifi
clinic
diagnost
result
collect
time
observ
put
clinic
cluster
abl
systemat
sequenc
influenzaposit
sampl
clinic
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
diagnost
laboratori
due
limit
manpow
laboratori
resourc
generalis
limit
sampl
approach
well
confound
influenc
unabl
control
includ
laboratori
clinic
influenc
eg
divers
sampl
type
sampl
exposur
freezethaw
underli
immunocompromis
symptom
durat
prior
sampl
collect
metagenom
data
hold
promis
simultan
detect
pathogen
individu
clinic
sampl
pose
gener
challeng
analyz
distinguish
pathogen
commens
flora
potenti
contamin
accur
interpret
base
upon
clinic
context
patient
type
qualiti
sampl
absolut
rel
abund
organ
metagenom
genom
coverag
map
depth
occurr
organ
sampl
run
multiplex
histor
run
laboratori
expert
casebycas
apprais
current
requir
data
use
clinic
decisionmak
summari
demonstr
feasibl
appli
nanopor
sequenc
clinic
set
simultan
detect
influenza
respiratori
virus
identifi
drug
resist
mutat
character
genet
divers
investig
potenti
nosocomi
transmiss
event
work
still
need
refin
streamlin
sequenc
protocol
bioinformat
analysi
nanopor
metagenom
sequenc
potenti
becom
applic
pointofcar
test
infecti
diseas
clinic
set
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
studi
anonymis
discard
clinic
sampl
approv
london
queen
squar
research
ethic
committe
follow
remov
human
read
sequenc
data
upload
european
bioinformat
institut
http
wwwebiacuk
project
refer
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
hazara
viru
spike
intern
control
genom
copiesml
c
coverag
iav
consensu
sequenc
ct
valu
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
distanc
pair
sequenc
denot
number
adjac
branch
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
